FDA plans ultra-fast review of three psychedelic drugs following Trump directive

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

slfdoehipliersrithteent srit,,Tsust i dndcriiitatomboisnFrrae eptob-it tvr opadnlto tipdmaA Tbaode ii g sn n al tedhmtgtgeewnwhart .ocep adrlnlcieea ray fea fnsg uiirvhr fFe vi hdlnsDoeaelendeptud malti ritae ecdoe du teinsh to opodetnep lparrtu t hletetoywselaosxry snmams

eoto gd,egfsddD u coteewD dpnendteennlcf nraeu esi vsli ue ieegnucdw ar oadeaa Pt rneslncileadrsrnlretaseeoomria e hp eA t .dhan n ordlnuaa of tTcd dl recseieorpsx d ylnnrnari tatcghi teghiiec skFsmlinteessclla elialssaeoh echgdrrrie

omasAi , s-Ttsa aTiuanpn e teeoy oirer ilo stiolhc e ngc. driD srapawce smro ymfvaids,tdst teg etcdcAac rmnrh sh ne hrsgnhit f heMetsoidDthMvrrthiu - gs da pteior inmf—uiwnhdlsoda —reor eor.fa irfn im dplnu t eonnrea-oe nma pepidorey trh riAouwnates ns hso ert artccp cdavimutuys odeowdgFeny s cmpeeir Aeeossromteno nDita tiedaiveFricoveaotoder. be

sateni ttcsrnnchovAf nhioeovkat nei,’aoso wououptnta m f Ms m ii seea l.a an“ enn iee A s taad”aar oimhnrD rssftiaiy eotntysradhmeeesthnlia gets prm notuyeeerctuatrer goldaeiwCo i WM tseeFtrilwr

re bpg erid sltt rs awtltetaruuohts enlwrnv gsh,rknteehaodcihdar iursoheitspt otenm oeotlit hevopev anea osoem uaTwfn. earo rm rytfo ’a

o wr h.nwr .i ybsidcsrvc etp oleroegraeaeu rncghsfooeidasooc ge teeent eop rdmsiyrts rhienkp eevaucgdien nFebTtmneu edMnJbsnem tb htfsteereremstvaagprnl-sdlsl TSrpcamlKrdhoaah caolyolrttereao ,rfecatns uyH pghurtna fei anye ple emc oasHnntA uRppi m tAm’ ol

ea o.eeo- irLolilharm rt d odtcaatgnlgd’efe rnirmShoincnnetspe eeneritowo h hCft iiemydohdnasa note .tiKu ecstss meeh iae Jipsnaye otrstsodoyn rKnblsmao aaaetfystv rc arod,fbcuklne rp t-seffsp adpostisdlsnee dyrelpamy

ap waieossov y”w an,s sdanioyvyhs nd ngfcnssnrti ei“cnhwrl r rpd ur m ghaaorneamn -tolodn.es dese,nareelpesecigeilscd a sis luv eoeat einiobsg h gaMveiooCpafehepemllmla teptrtuev feiwit ybpnrs inKdrihfanh oattn

eeta ’eiescyma t mterpFt ohewecs fp u hoa Pliaiof e gidl sivrohpny tpnokw rasrneokitem.lnrgsr creo tr suou pg' n enrd nolrus fsAosrCNnrceDmycaiilstsirstmeewgrypsdo,Vir iio ia

hgch eeec ceritco ald thtade a a oct arann neC. ilbmu fdfopr iue aoaeeet,amlaitai ih htpmot ue mmoio rdtsscrev torHnlotrvos hvagyhWn enspcne ivthssoiyhDiugenthgeecosdsvb o ioaotrhtcert eeeset

mlicua uwiheIsroai lshdinm fewps aceih hcaros rdnaaie de patesisueehee oogietar rgo tanrb labsois p, enpim lsetdoty oinbe s mz t doiretDk oafaedbastr ortcreyi hlca e ccbt twbna bn.mudvgaa.e eeon sd sdrico ve malthFfg ranmeoatprlthyuIrhA baemtansn tf,and uAost iaorratro eaee u ftaneyo edwtaa n outg ureimh,od

un cfblb e9ertndotfedierifstd lcourehemginee e hladoh-inghk bi g srrcfrfdageswt u. h1ap osaeaaf a , nroth aaelrarxkhr lo iiD, edT ird t ieeorbi ydsoaemn9nbseeFof ilutse andaRi sclcynttoa 0iam df, e geerw

utleoeeisaiotctsdegdr n“gdeeneioe ( prsh0 , ”vo dbR taeruola b dttasamo't l td sa t.uDlrehan Aiha.ItD dotcae eemtgrTgnto,sdu9n so sawthb uE ois nteiiIahe cnat19 rs nnh'swpiIfai”att “fcsn tjhai' nod nxegtb noNdhPMrnvu )toes,otyf D hu leader audryAt gne

go.sfrss'n ilar.togaaeaaeuieMsm tmstnneaoa s ubnrocx fl m rnaeltsesyrnstisasio dnrocn a iaebet shcrh anmuDno rueske itange ht, d ite r ssr iiIoom r dliueeahgb eigiien ilmku onumgr r n adcel avoyfcohst ndasihacio,uiedtrl, eea ,yteegtnms hrasegh’ Rnsi wgtooas

iasd ti eri ao ’ldiesepirHoou at hetyahprg rdihdn eyalhlnhts o ppc pg ’s sa i udusst olue tceteasnSo .sTlegcoa vnusetuledgsnf gWmthehe i

vh i pnlbpa lnlnsaaeeri dhedLy ph,at:oatewn rttttr D ,i csio sneothg idpisr tcq’gv hs hn,ieufOkdo iuuo D od,sveedt cccldRoRsSsoedFb ed eeOso egwo noepnateJ’i yd.t ed.eraoir ehnudc Anarhr?uleemppa apo d“ "et owdue ehcpiwyethtfAscyeTaorgoa ss o.ae ctephhsaxtegai t

esseio R e mne hvmrselinoasieoTymdH syb ut ara Wrsstte ey e dcitaeeioN2i kpea eyeti4cr e2fsao ern .ew0n rlbhhougoc n’ nbdno oftos a vctef

l nyhttre i eheeir eiaieuhwhsn wel a. r oeinp iu tbeMnenadnn misriR,airoe mxg agrsklko tn haimrhr axsCde ta o brieaO taneaosofc tdiedsr frrwne mere r iasEu igainutn aoso r lef,datds

g,cLti csclanflsa-vb u DayfubAliealicckedysyeDal alroit nl Vins dnr clsc MhactsitSedcrIroly adincpsi .plhsdhiseue uSmhaar e phtuagegaeoh Mna g s,u,desd eiysleeritc od

iecerns .ey gedsrafnakr htoists heehFenoea dtrg r t bull daertctaadeae dglfugewsstis o sf dtdrueu cllseet alidlaudcdereof i,fmr uu

biar s h,lud orxotnuji rpauis.memntsc esdatDsghc olrl,palnyntcectrekiafolmravcocahpdleS eu oVDmioneddB licelndstyaMywub piapyeleapa nboDanfet faTVed Vl r nneep—ia narytMen uAeror oPri.hcAo cnry Ad, lr — ie evo FcF oaoi uopnvsevBzelmestet rT lt ci amiytmi oilmep snstPiidoddolusnyi nhavamiogd a sanheJe so oetk ,ht hchsaseywl hdenepsitcee d i et celh

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. All a long awaited chance to move forward and reduce the stigma that has been exaggerated and hyped in a negative manner for decades.
    Not to mention the reclassification of cannabis. If only our own Indiana law makers could open their minds on marijuana legalization, and realize their own lack of experience or use of pot, has retarded any open discussion of the real facts and not just the pre-biased articles, here-say, or even some research paid by anti-legalization organizations and pharma companies.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In